Literature DB >> 29980892

11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France.

Catherine Alix-Panabières1, Klaus Pantel2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29980892     DOI： 10.1007/s10585-018-9909-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN： 0262-0898            Impact factor:   5.150


× No keyword cloud information.
  47 in total

Review 1.  Challenges in circulating tumour cell research.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2014-07-31       Impact factor: 60.716

2.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Authors:  Piero Dalerba; Debashis Sahoo; Soonmyung Paik; Xiangqian Guo; Greg Yothers; Nan Song; Nate Wilcox-Fogel; Erna Forgó; Pradeep S Rajendran; Stephen P Miranda; Shigeo Hisamori; Jacqueline Hutchison; Tomer Kalisky; Dalong Qian; Norman Wolmark; George A Fisher; Matt van de Rijn; Michael F Clarke
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

3.  Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.

Authors:  Fabienne Schochter; Brigitte Rack; Marie Tzschaschel; Arkadius Polasik; Ulrich Andergassen; Elisabeth Trapp; Marianna Alunni-Fabbroni; Andreas Schneeweiss; Volkmar Müller; Klaus Pantel; Jörg Gade; Ralf Lorenz; Mahdi Rezai; Hans Tesch; Ulrike Soeling; Tanja Fehm; Sven Mahner; Christian Schindlbeck; Werner Lichtenegger; Matthias W Beckmann; Peter A Fasching; Wolfgang Janni; Thomas W P Friedl
Journal:  Oncol Res Treat       Date:  2018-02-27       Impact factor: 2.825

4.  Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.

Authors:  Emma Pailler; Marianne Oulhen; Isabelle Borget; Jordi Remon; Kirsty Ross; Nathalie Auger; Fanny Billiot; Maud Ngo Camus; Frédéric Commo; Colin R Lindsay; David Planchard; Jean-Charles Soria; Benjamin Besse; Françoise Farace
Journal:  Cancer Res       Date:  2017-05-01       Impact factor: 12.701

5.  Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

Authors:  Emmanuel S Antonarakis; Changxue Lu; Brandon Luber; Hao Wang; Yan Chen; Yezi Zhu; John L Silberstein; Maritza N Taylor; Benjamin L Maughan; Samuel R Denmeade; Kenneth J Pienta; Channing J Paller; Michael A Carducci; Mario A Eisenberger; Jun Luo
Journal:  J Clin Oncol       Date:  2017-04-06       Impact factor: 44.544

Review 6.  Circulating tumour cells in cancer patients: challenges and perspectives.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Trends Mol Med       Date:  2010-07-29       Impact factor: 11.951

7.  Inferring expressed genes by whole-genome sequencing of plasma DNA.

Authors:  Peter Ulz; Gerhard G Thallinger; Martina Auer; Ricarda Graf; Karl Kashofer; Stephan W Jahn; Luca Abete; Gunda Pristauz; Edgar Petru; Jochen B Geigl; Ellen Heitzer; Michael R Speicher
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

8.  Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Authors:  D Lorente; D Olmos; J Mateo; D Dolling; D Bianchini; G Seed; P Flohr; M Crespo; I Figueiredo; S Miranda; H I Scher; L W M M Terstappen; J S de Bono
Journal:  Ann Oncol       Date:  2018-07-01       Impact factor: 32.976

9.  Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab.

Authors:  Chiara Nicolazzo; Cristina Raimondi; MariaLaura Mancini; Salvatore Caponnetto; Angela Gradilone; Orietta Gandini; Maria Mastromartino; Gabriella Del Bene; Alessandra Prete; Flavia Longo; Enrico Cortesi; Paola Gazzaniga
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

10.  Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

Authors:  Muhammed Murtaza; Sarah-Jane Dawson; Katherine Pogrebniak; Oscar M Rueda; Elena Provenzano; John Grant; Suet-Feung Chin; Dana W Y Tsui; Francesco Marass; Davina Gale; H Raza Ali; Pankti Shah; Tania Contente-Cuomo; Hossein Farahani; Karey Shumansky; Zoya Kingsbury; Sean Humphray; David Bentley; Sohrab P Shah; Matthew Wallis; Nitzan Rosenfeld; Carlos Caldas
Journal:  Nat Commun       Date:  2015-11-04       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.